NantHealth, Inc. (NHIQ)
USD 0.25
(12399.98%)
USD 0.25
(12399.98%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | 67 Million | 62.64 Million | 73.17 Million | 95.96 Million | 89.46 Million | 86.67 Million |
| Cost of Revenue | 28.83 Million | 27.8 Million | 29.22 Million | 38.42 Million | 44.26 Million | 41.52 Million |
| Gross Profit | 38.16 Million | 34.84 Million | 43.94 Million | 57.53 Million | 45.19 Million | 45.15 Million |
| Operating Expenses | 94.47 Million | 75.74 Million | 69.48 Million | 84.33 Million | 95.89 Million | 113.05 Million |
| Selling, General and Administrative Expenses | 62.5 Million | 52.09 Million | 48.53 Million | 61.04 Million | 70.76 Million | 74.97 Million |
| Research and Development Expenses | 23.04 Million | 19.7 Million | 17.27 Million | 19.07 Million | 20.91 Million | 33.86 Million |
| Other Expenses | 3.94 Million | -3.08 Million | -10.82 Million | -5.62 Million | -17.87 Million | 800 Thousand |
| Cost and Expenses | 118.32 Million | 103.54 Million | 98.71 Million | 122.75 Million | 140.16 Million | 154.57 Million |
| Operating Income | -51.32 Million | -40.89 Million | -26.26 Million | -30.77 Million | -50.7 Million | -67.9 Million |
| Interest Expense | 14.11 Million | 14.48 Million | 19.19 Million | 18.04 Million | 17.12 Million | 16.16 Million |
| Income Tax Expense | -317 Thousand | 97 Thousand | 447 Thousand | -112 Thousand | -3.67 Million | -2.2 Million |
| Earnings before Tax | -68.09 Million | -58.46 Million | -87.99 Million | -62.75 Million | -194.1 Million | -133.6 Million |
| Net Income | -67.77 Million | -58.25 Million | -56.32 Million | -62.76 Million | -192.15 Million | -175.21 Million |
| Earnings Per Share Basic | -8.80 | -7.66 | -7.61 | -8.53 | -26.40 | -22.51 |
| Earnings Per Share Diluted | -8.80 | -7.66 | -7.61 | -8.53 | -26.40 | -22.51 |
| Weighted Average Shares Outstanding | 7.7 Million | 7.6 Million | 7.39 Million | 7.35 Million | 7.27 Million | 7.78 Million |
| Weighted Average Shares Outstanding (Diluted) | 7.7 Million | 7.6 Million | 7.39 Million | 7.35 Million | 7.27 Million | 7.78 Million |
| Gross Margin | 0.57 | 0.56 | 0.60 | 0.60 | 0.51 | 0.52 |
| EBIT Margin | -0.58 | -0.64 | -0.88 | -0.38 | -1.93 | -1.31 |
| Profit Margin | -1.01 | -0.93 | -0.77 | -0.65 | -2.15 | -2.02 |
| EBITDA | -38.53 Million | -28.26 Million | -52.96 Million | -27.2 Million | -154.63 Million | -98.2 Million |
| Earnings Before Tax Margin | -0.77 | -0.65 | -0.36 | -0.32 | -0.57 | -0.78 |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 12.46 Million | 17.25 Million | 17.05 Million | 67 Million | 17.49 Million | 16.63 Million |
| Cost of Revenue | 5.41 Million | 5.7 Million | 6.42 Million | 28.83 Million | 7.38 Million | 6.92 Million |
| Gross Profit | 7.05 Million | 11.54 Million | 10.62 Million | 38.16 Million | 10.11 Million | 9.7 Million |
| Operating Expenses | 12.06 Million | 20.27 Million | 22.85 Million | 89.49 Million | 23.08 Million | 23.86 Million |
| Selling, General and Administrative Expenses | 8.71 Million | 12.63 Million | 16.7 Million | - | 16.92 Million | 16.58 Million |
| Research and Development Expenses | 2.36 Million | 6.66 Million | 5.16 Million | - | 5.17 Million | 6.29 Million |
| Other Expenses | 447 Thousand | -4.05 Million | 4.21 Million | -2.65 Million | -9.3 Million | 4 Million |
| Cost and Expenses | 17.47 Million | 25.98 Million | 29.27 Million | 118.32 Million | 30.46 Million | 30.79 Million |
| Operating Income | -10.51 Million | -8.72 Million | -12.22 Million | -51.32 Million | -12.96 Million | -14.15 Million |
| Interest Expense | 4.86 Million | 4.79 Million | 4.15 Million | 14.11 Million | 3.68 Million | 3.51 Million |
| Income Tax Expense | 54 Thousand | -94 Thousand | 74 Thousand | -317 Thousand | -298 Thousand | -10 Thousand |
| Earnings before Tax | -14.93 Million | -17.57 Million | -12.16 Million | -68.09 Million | -25.95 Million | -13.66 Million |
| Net Income | -14.98 Million | -17.48 Million | -12.24 Million | -67.77 Million | -25.66 Million | -13.65 Million |
| Earnings Per Share Basic | -1.00 | -2.27 | -1.59 | - | -3.33 | -1.77 |
| Earnings Per Share Diluted | -1.00 | -2.27 | -1.59 | - | -3.33 | -1.77 |
| Weighted Average Shares Outstanding | 15 Million | 7.7 Million | 7.7 Million | 7.7 Million | 7.7 Million | 7.7 Million |
| Weighted Average Shares Outstanding (Diluted) | 15 Million | 7.7 Million | 7.7 Million | 7.7 Million | 7.7 Million | 7.7 Million |
| Gross Margin | 0.57 | 0.67 | 0.62 | 0.57 | 0.58 | 0.58 |
| EBIT Margin | -0.06 | -0.57 | -0.30 | - | -1.04 | -0.37 |
| Profit Margin | -1.20 | -1.01 | -0.72 | -1.01 | -1.47 | -0.82 |
| EBITDA | -740 Thousand | -9.78 Million | -5.06 Million | - | -18.18 Million | -6.14 Million |
| Earnings Before Tax Margin | -0.84 | -0.51 | -0.72 | -0.77 | -0.74 | -0.85 |
KTWIF
AJANTPHARM
7472
1157
GMLA
8028